CONGRESS|#EHA2021| Juan-José Garcés @idisnanavarra presented that circulating tumor cells (CTC) were the most relevant prognostic factor at baseline in MM pts. Undetectable MRD should be the treatment endpoint for CTC elevated pts as they showed long-term survival #mmsm #myeloma pic.twitter.com/BZedXZprU2
— Multiple Myeloma Hub (@MM_Hub) June 15, 2021